A Comparison of Therapy-Related and De Novo Chronic Myelomonocytic Leukemia

被引：0
|
作者：
Ordobazari, A. [1 ]
Olteanu, H. [1 ]
Kroft, S. H. [1 ]
Harrington, A. M. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1518
引用
收藏
页码：369A / 369A
页数：1
相关论文
共 50 条
  • [21] Outcome of Patients (pts) with Therapy-Related De Novo Acute Myeloid Leukemia (t-de novo AML): Single Institution Experience
    Sasaki, Koji
    Jabbour, Elias
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Pierce, Sherry R.
    Pemmaraju, Naveen
    O'Brien, Susan
    Ravandi, Farhad
    BLOOD, 2014, 124 (21)
  • [22] Therapy-related MDS after curative intensive therapy for de novo acute myeloid leukemia - An emerging clinical entity?
    Helas, S.
    Roellig, C.
    Duehrsen, U.
    Herbst, R.
    Schaich, M.
    Thiede, C.
    Mohr, B.
    Kramer, M.
    Trautmann-Grill, K.
    Von Bonin, M.
    Bornhaeuser, M.
    Ehninger, G.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2013, 37 : S139 - S139
  • [23] THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    ROBERTSON, LE
    ESTEY, E
    KANTARJIAN, H
    KOLLER, C
    OBRIEN, S
    BROWN, B
    KEATING, MJ
    LEUKEMIA, 1994, 8 (12) : 2047 - 2051
  • [24] Characteristics and Outcomes of Patients With Multiple Myeloma Who Develop Therapy-Related Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Pemmaraju, Naveen
    Shah, Dhaval
    Kantarjian, Hagop
    Orlowski, Robert Z.
    Gonzalez, Graciela M. Nogueras
    Baladandayuthapani, Veera
    Jain, Nitin
    Wagner, Verena
    Garcia-Manero, Guillermo
    Shah, Jatin
    Ravandi, Farhad
    Pierce, Sherry
    Takahashi, Koichi
    Daver, Naval
    Nazha, Aziz
    Verstovsek, Srdan
    Jabbour, Elias
    De Lima, Marcos
    Champlin, Richard
    Cortes, Jorge
    Qazilbash, Muzaffar H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (02): : 110 - 114
  • [25] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
    Yarosh, Rina
    Roesler, Michelle A.
    Murray, Thomas
    Cioc, Adina
    Hirsch, Betsy
    Nguyen, Phuong
    Warlick, Erica
    Poynter, Jenny N.
    CANCER CAUSES & CONTROL, 2021, 32 (03) : 241 - 250
  • [26] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
    Rina Yarosh
    Michelle A. Roesler
    Thomas Murray
    Adina Cioc
    Betsy Hirsch
    Phuong Nguyen
    Erica Warlick
    Jenny N. Poynter
    Cancer Causes & Control, 2021, 32 : 241 - 250
  • [27] Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
    Shao, Haigang
    Yang, Qian
    Wu, Chunxiao
    Cen, Jiannong
    Chen, Suning
    Pan, Jinlan
    ANNALS OF HEMATOLOGY, 2017, 96 (12) : 2127 - 2129
  • [28] Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
    Haigang Shao
    Qian Yang
    Chunxiao Wu
    Jiannong Cen
    Suning Chen
    Jinlan Pan
    Annals of Hematology, 2017, 96 : 2127 - 2129
  • [29] De Novo and Therapy-Related Pure Erythroid Leukemia Harbor Distinct TP53 Genetic Alterations
    Tashakori, Mehrnoosh
    Wang, Wei
    Wang, Sa
    Kanagal-Shamanna, Rashmi
    Loghavi, Sanam
    Medeiros, L. Jeffrey
    Tapan, Kadia
    Daver, Naval
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 898 - 900
  • [30] Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts
    Chen, Zhining
    Wang, Sa A.
    Goswami, Maitrayee
    Tang, Guilin
    Routbort, Mark J.
    Patel, Keyur P.
    Luthra, Rajyalakshmi
    Medeiros, L. Jeffrey
    Ok, Chi Young
    LEUKEMIA RESEARCH, 2019, 86
12345